0
0

Vaccine Accountability and Premium Protection Act

12/30/2022, 7:18 AM

Summary of Bill HR 5622

Bill 117 HR 5622, also known as the Vaccine Accountability and Premium Protection Act, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to hold vaccine manufacturers accountable for any adverse reactions that may occur as a result of receiving a vaccine.

The bill proposes the creation of a Vaccine Injury Compensation Program, which would provide financial compensation to individuals who experience serious side effects from vaccines. This program would be funded by a small fee on each vaccine dose administered.

Additionally, the bill aims to protect individuals from being denied health insurance coverage or facing increased premiums due to receiving a vaccine. It prohibits insurance companies from discriminating against individuals based on their vaccination status. Overall, the Vaccine Accountability and Premium Protection Act seeks to ensure that individuals are able to receive vaccines without fear of financial repercussions and that vaccine manufacturers are held responsible for any harm caused by their products. It is currently being debated in Congress and may undergo changes before potentially becoming law.

Congressional Summary of HR 5622

Vaccine Accountability and Premium Protection Act

This bill permits a health insurer to increase an individual's plan premium by not more than 50% of the base amount during any portion of the COVID-19 public health emergency if the insured individual is not fully vaccinated. An insurer may not apply the premium increase unless certain conditions are met.

Current Status of Bill HR 5622

Bill HR 5622 is currently in the status of Bill Introduced since October 19, 2021. Bill HR 5622 was introduced during Congress 117 and was introduced to the House on October 19, 2021.  Bill HR 5622's most recent activity was Referred to the Subcommittee on Crime, Terrorism, and Homeland Security. as of November 1, 2022

Bipartisan Support of Bill HR 5622

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
0
Democrat Cosponsors
0
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 5622

Primary Policy Focus

Health

Potential Impact Areas

- Cardiovascular and respiratory health
- Emergency medical services and trauma care
- Fraud offenses and financial crimes
- Health care costs and insurance
- Health information and medical records
- Immunology and vaccination
- Infectious and parasitic diseases

Alternate Title(s) of Bill HR 5622

Vaccine Accountability and Premium Protection Act
To amend title XXVII of the Public Health Service Act to allow for premium rates in the group and individual health insurance markets to vary during the COVID-19 emergency period based on COVID-19 vaccination status, and for other purposes.
Vaccine Accountability and Premium Protection Act

Comments